Abstract
To elucidate the events elicited by the skin tumor promotor 12-O-tetradecanoylphorbol-13-acetate (TPA), which are modulated by linoleic acid (LA) and arachidonic acid (AA), the activity of these fatty acids in cultured mouse epidermal cells was compared. Approximately 94% of either exogenous radiolabelled fatty acid was incorporated into the total phospholipid pool over 15 h. The relative distribution among the phospholipid classes differed, however, such that approximately 70% of phospholipid-associated [14C]-LA was found in phosphatidylcholine, compared to approximately 30% for [14C]AA. Phosphatidylethanolamine and phosphatidylinositol/phosphatidylserine contained 17 and 13% of the phospholipid [14C]LA, and 34 and 30% of [14C]AA, respectively. Prostaglandin (PG) E2 production was low but similar in unstimulated cultures prelabelled with either [14C]LA or [14C]AA. However, in cultures treated with TPA (1.6 μM), [14C]AA-prelabelling resulted in approximately three times the amount of [14C]PGE2 compared with cultures prelabelled with [14C]LA. Cultured cells were found to contain significant δ6 desaturase activity, which may enable conversion of LA to AA, and thus may account for the observed PGE2 production from [14C]LA treated cells. AA-Supplemented (1.6 μM) cultures supported approximately twice the induction of ornithine decarboxylase activity by TPA compared with cultures treated with 1.8 μM LA. Activation of partially purified protein kinase C was similar for either fatty acid tested over a 10–300 μM dose range. Overall, the results suggest that LA does not have the same biological activity as AA with regard to several TPA-associated events known to be important in skin tumor promotion. This reduced biological activity of LA may be partly responsible for the known inhibition of mouse skin tumor promotion by high dietary levels of LA [Leyton, J., Lee, M.L., Locniskar, M.F., Belury, M.A., Slaga, T.J., Bechtel, D., and Fischer, S.M. (1991)Cancer Res. 51, 907–915].
Similar content being viewed by others
Abbreviations
- AA:
-
arachidonic acid
- ATP:
-
adenosine triphosphate
- DTT:
-
dithiothreitol
- EDTA:
-
ethylenediaminetetraacetic acid
- EGTA:
-
ethylureglycol-bis- (β-aminoethyl ether)N,N,N,N′,N′-tetraacetic acid
- HODE:
-
hydroxyoctadecadienoic acid
- LA:
-
linoleic acid
- γ-LN:
-
γ-linolenic acid
- ODC:
-
ornithine decarboxylase
- PC:
-
phosphatidylcholine
- PE:
-
phosphatidylethanolamine
- PI:
-
phosphatidylinositol
- PKC:
-
protein kinase C
- PMSF:
-
phenylmethylsulfonyl fluoride
- PS:
-
phosphatidylserine
- TLC:
-
thin-layer chromatography
- TPA:
-
12-O-tetradecanoyl-phorbol-13-acetate
References
Leyton, J., Lee, M.L., Locniskar, M., Belury, M.A., Slaga, T.J., Bechtel, D., and Fischer, S.M. (1991)Cancer Res. 51, 907–915.
Fischer, S.M., Conti, C.J., Locniskar, M., Belury, M.A., Maldve, R.E., Lee, M.L., Leyton, J., Slaga, T.J., and Bechtel, D.H. (1992)Cancer Res. 52, 661–666.
Cohen, L.A., Thompson, D.O., Maeura, Y., Choi, K., Blank, M.E., and Rose, D.P. (1986)J. Natl. Cancer Inst. 77, 33–42.
Carroll, K.K., and Khor, H.T. (1971)Lipids 6, 415–420.
Roebuck, B.D., Longnecker, D.S., Baumgartner, K.J., and Thron, C.D. (1985)Cancer Res. 45, 5252–5256.
Bull, A.W., Bronstein, J.C., and Nigro, N.D. (1989)Lipids 24, 340–346.
Ip, C., Carter, C.A., and Ip, M.M. (1985)Cancer Res. 45, 1997–2001.
O'Connor, T.P., Roebuck, B.D., Peterson, F.J., Lokesh, B., Insella, J.E., and Campbell, T.C. (1989)J. Natl. Cancer Inst. 81, 858–963.
Reddy, B.S., and Maruyama, H. (1986)Cancer Res. 46, 3367–3370.
Abou-El-Ela, S.H., Prasse, K.W., Farrell, R.L., Carroll, R., Wade, A.E., and Bunce, O.R. (1989)Cancer Res. 49, 1434–1440.
Locniskar, M., Belury, M.A., Cumberland, A.G., Patrick, K.E., and Fischer, S.M. (1990)Carcinogenesis (Lond.) 11, 1641–1645.
Isseroff, R.R., Ziboh, V.A., Chapkin, R.S., and Martinez, D.T. (1984)J. Lipid Res. 28, 1342–1349.
Fischer, S.M., Cameron, G.S., Baldwin, J.K., Jasheway, D.W., Patrick, K.E., and Belury, M.A. (1989)Skin Carcinogenesis: Mechanisms and Human Relevance, pp. 249–264, Alan R. Liss, New York.
Rao, G.A., and Abraham, S. (1977)J. Natl. Cancer Inst. 58, 445–447.
Carter, C.A., Milholland, R.J., Shea, W., and Ip, M.M. (1983)Cancer Res. 43, 3559–3562.
Verma, A.K., Ashendel, C.L., and Boutwell, R.K. (1980)Cancer Res. 40, 308–315.
Weinstein, I.B. (1988)Mutation Res. 202, 413–420.
Lester, D.S., Collin, C., Etcheberrigaray, R., and Alkon, D.L. (1991)Biochem. Biophys. Res. Commun. 179, 1522–1528.
Sekiguchi, K., Tsukuda, M., Ogita, K., Kikkawa, Y., and Nishizuka, Y. (1987)Biochem. Biophys. Res. Commun. 145, 797–802.
Murakami, K., and Routtenberg, A. (1985)FEBS Lett. 192, 189–193.
Fischer, S.M., O'Connell, J.F., Conti, C.J., Tacker, K.C., Fries, J.W., Patrick, K.E., Adams, L.M., and Slaga, T.J. (1987)Carcinogenesis 6, 41–44.
Yuspa, S.H., and Harris, C.C. (1974)Exp. Cell Res. 86, 95–105.
Morris, R.J., Tacker, K.C., Baldwin, J.K., Fischer, S.M., and Slaga, T.J. (1987)Cancer Lett. 34, 297–304.
Chapkin, R.S., and Ziboh, V.A. (1984)Biochem. Biophys. Res. Commun. 124, 784–792.
Marcel, Y.L., Christiansen, K., and Holman, R.T. (1968)Biochim. Biophys. Acta 164, 25–34.
Smith, P.K., Krohn, R.I., Mallia, A.K., Provenzano, M.D., Fujimoto, E.K., Goekem, N.M., Olson, B.J., and Klenk, D.C. (1985)Anal. Biochem. 150, 76–85.
Flower, R.J., and Blackwell, G.J. (1976)Biochem. Pharmacol. 25, 285–291.
Belury, M.A., Patrick, K.E., Locniskar, M., and Fischer, S.M. (1989)Lipids 24, 423–429.
Weeks, C.E., and Slaga, T.J. (1979)Biochem. Biophys. Res. Commun. 91, 1488–1496.
Ashendel, C.L., Staller, J.M., and Boutwell, R.K. (1983)Cancer Res. 43, 4327–4332.
Rohrschneider, L.R., O'Brian, D.H., and Boutwell, R.K. (1972)Biochim. Biophys. Acta 280, 57–70.
Rohrschneider, L.R., and Boutwell, R.K. (1973)Cancer Res. 33, 1945–1952.
Nugteren, D.H., and Kivits, G.A.A. (1987)Biochim. Biophys. Acta 921, 135–141.
Nugteren, D.H., Christ-Hazelhof, E., van der Beek, A., and Houtsmuller, U.M.T. (1985)Biochim. Biophys. Acta 834, 429–436.
Claeys, M., Coene, M.C., Herman, A.G., Jouvenez, G.H., and Nugteren, D.H. (1982)Biochim. Biophys. Acta 713, 160–169.
Miller, C.C., and Ziboh, V.A. (1990)J. Invest. Dermatol. 94, 353–358.
Belury, M.A., Lee, W-Y., Lo, H-H., Locniskar, M.F., and Fischer, S.M. (1993)Nutr. Cancer, in press.
Fürstenberger, G., and Marks, F. (1978)Biochem. Biophys. Res. Commun. 84, 1103–1111.
Verma, A.K., and Boutwell, R.K. (1977)Biochem. Biophys. Res. Commun. 79, 1160–1166.
Fürstenberger, G., and Marks, F. (1980)Biochem. Biophys. Res. Commun. 92, 749–756.
Bunce, O.R., and Abou-El-Ela, S.H. (1990)Prostaglandins, Leukotrienes and Essential Fatty Acids 41, 105–113.
Reddy, B.S., and Sugie, S. (1988)Cancer Res. 48, 6642–6647.
Orengo, I.F., Black, H.S., Kettler, A.H., and Wolf, Jr., J.E. (1989)Photochem. Photobiol. 49:71–77.
Solanki, V., and Slaga, T.J. (1981)Proc. Natl. Acad. Sci. USA 78, 2549–2553.
O'Brian, C.A., Ward, N.E., Weinstein, I.B., Bull, A.W., and Marnett, L.J. (1988)Biochem. Biophys. Res. Commun. 155, 1374–1380.
Seifert, R., Schächtele, C., Rosenthal, W., and Schultz, G. (1988)Biochem. Biophys. Res. Commun. 154, 20–26.
Craven, P.A., and DeRubertis, F.R. (1988)Gastroenterology 95, 676–685.
Author information
Authors and Affiliations
About this article
Cite this article
Belury, M.A., Locniskar, M. & Fischer, S.M. Modulation of phorbol ester-associated events in epidermal cells by linoleate and arachidonate. Lipids 28, 407–413 (1993). https://doi.org/10.1007/BF02535938
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02535938